Role of the tumor suppressor IQGAP2 in metabolic homeostasis: possible link between diabetes and cancer
- 454 Downloads
Deficiency of IQGAP2, a scaffolding protein expressed primarily in liver leads to rearrangements of hepatic protein compartmentalization and altered regulation of enzyme functions predisposing development of hepatocellular carcinoma and diabetes. Employing a systems approach with proteomics, metabolomics and fluxes characterizations, we examined the effects of IQGAP2 deficient proteomic changes on cellular metabolism and the overall metabolic phenotype. Iqgap2 −/−mice demonstrated metabolic inflexibility, fasting hyperglycemia and obesity. Such phenotypic characteristics were associated with aberrant hepatic regulations of glycolysis/gluconeogenesis, glycogenolysis, lipid homeostasis and futile cycling corroborated with corresponding proteomic changes in cytosolic and mitochondrial compartments. IQGAP2 deficiency also led to truncated TCA-cycle, increased anaplerosis, increased supply of acetyl-CoA for de novo lipogenesis, and increased mitochondrial methyl-donor metabolism necessary for nucleotides synthesis. Our results suggest that changes in metabolic networks in IQGAP2 deficiency create a hepatic environment of a ‘pre-diabetic’ phenotype and a predisposition to non-alcoholic fatty liver disease which has been linked to the development of hepatocellular carcinoma.
KeywordsIQGAP2 Metabolic inflexibility Hepatocellular carcinoma Diabetes Warburg-like Anaplerosis
Authors would sincerely like to thank Dr. Schmidt VA (SUNY, Stony Brook) for the kind gift of Iqgap2 −/− mice for the study. Proteome research efforts (J.E.B, A.N, C.Z) were supported by grants 5R01GM086688, 1U19AI10777, 5R01AI101307, and 5R01HL110879. I.J.K., was supported by DK58132-01A2 and Diabetes Research and Training Center (DRTC), NIH grant P60DK020541, I.J.K and C.G were supported by NIAID grant U19AI091175-01. L.W.N.P was supported by the biomedical mass spectrometry laboratory at Harbor-UCLA, partly supported by the Clinical and Translational Science Institute at UCLA (UL1 TR000124) and the Center of Excellence for Pancreatic Diseases (PO1 AT00396).
- Shannon, K. B. (2012). IQGAP family members in yeast, dictyostelium, and mammalian cells. Internation Journal of Cell Biology, 2012, 894817.Google Scholar
- Zhong, S., et al. (1994). Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. The Journal of Clinical Investigation, 94(6), 2457–2467.CrossRefPubMedPubMedCentralGoogle Scholar